Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEXECUTIVESExperienced Medical Device Executives Charlie Huiner and Mitch Levinson Added to Recros Medica BOD

Experienced Medical Device Executives Charlie Huiner and Mitch Levinson Added to Recros Medica BOD

October 20, 2020

Charlie Huiner and Mitch Levinson have been added to Recros Medica Board of Directors. Recros Medica is an aesthetic company focused on developing medical devices to reduce skin laxity and improve focal contouring via its Nuvellus® Focal Contouring system. The Nuvellus® platform, based on the company’s proprietary rotational fractional resection technology, may offer a novel procedure that produces results from a single treatment. Nearly 100 subjects have been treated in four IRB-approved clinical trials, and the Company is currently planning a pivotal clinical study that is planned to begin in the third quarter of 2021. The company is also developing Nuvellus® to facilitate autologous dermal transfer, as a natural alternative to commercial dermal fillers.

Charlie Huiner is an experienced executive in the aesthetic medical device sector, having worked as a senior executive at Inamed, Isologen, and Sientra among others. Mitch Levinson was a Co-Founder and the first CEO of Zeltiq, a successful aesthetic device company that was acquired in 2017 for $2.5 billion. The bios of Charlie and Mitch, as well as the other Board Directors.

“We are thrilled to announce the addition of Charlie and Mitch to our Board of Directors. Charlie’s extensive background in finance, business development, and commercialization and Mitch’s expertise as an engineer with an extensive background in R&D and general management offer valuable additions to our current Board without significant overlap of experience,” stated Tom Albright, president, and CEO of Recros Medica. Tom added, “We believe Charlie and Mitch will provide distinct insights to enhance our corporate strategy going forward.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy